Capricor Therapeutics CAPR
NASDAQ CAPR
$8.95 +0.01 (+0.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Change in Accured Expenses (2010 - 2026)

Updated

Capricor Therapeutics (CAPR) posted Change in Accured Expenses of $1.94 million for Q2 2026, up 27.1% from $1.53 million a year earlier.

Analysis

Capricor Therapeutics (CAPR) Change in Accured Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Capricor Therapeutics was $2 million, down 58.8% year-over-year; for FY2025, it was $5.98 million, up 208.3% from FY2024.

  • Annual Change in Accured Expenses shows a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
  • In prior years, Capricor Therapeutics' Change in Accured Expenses was $1.94 million in FY2024 (+46.4%), $1.33 million in FY2023 (-22.8%), $1.72 million in FY2022 (+328.8%) and $400,750 in FY2021 (-78.2%).
  • Quarterly Change in Accured Expenses has run from a low of -$3.08 million in Q1 2026 to a high of $2.17 million in Q4 2025 over five years.
  • On a year-over-year basis, Change in Accured Expenses increased in three of the last four quarters, with growth averaging 37.1%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q3 2025, with growth of 168.8%; the weakest was Q3 2024, with a decline of 78.2%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$3.08 million (Q1 2026), $2.17 million (Q4 2025) and $971,647 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Capricor Therapeutics 520.08 Mn 520.08 Mn - 1.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.94 Mn
Mar 31, 2026 -3.08 Mn
Dec 31, 2025 2.17 Mn
Sep 30, 2025 971,647.00
Jun 30, 2025 1.53 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 1.66 Mn
Sep 30, 2024 361,429.00
Jun 30, 2024 -78,723.00
Mar 31, 2024 -1,584.00
Dec 31, 2023 -541,709.00
Sep 30, 2023 1.66 Mn
Jun 30, 2023 -291,923.00
Mar 31, 2023 501,815.00
Dec 31, 2022 982,327.00
Sep 30, 2022 724,520.00
Jun 30, 2022 -395,738.00
Mar 31, 2022 407,203.00
Dec 31, 2021 625,159.00
Sep 30, 2021 -306,800.00
API Access

Capricor Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CAPR&period=max&api_key=YOUR_API_KEY